The Association between Eye Sign and Capillaroscopy Changes in Patients with Scleroderma Spectrum Disease Presenting with Raynaud's Phenomenon, as Compared to the Normal Population.
{"title":"The Association between Eye Sign and Capillaroscopy Changes in Patients with Scleroderma Spectrum Disease Presenting with Raynaud's Phenomenon, as Compared to the Normal Population.","authors":"Saeedeh Shenavandeh, Sanaz Dehghani","doi":"10.47176/mjiri.40.28","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Capillaroscopy is widely recognized for its role in evaluating microcirculation, particularly in patients with Raynaud's phenomenon and scleroderma-spectrum diseases. The eye sign may provide complementary insights into microvascular assessment. This study primarily investigates whether the eye sign can differentiate patients with systemic sclerosis (SSc) and other connective tissue diseases (CTDs) presenting with Raynaud's from healthy controls. Additionally, we explored correlations between eye sign scores and capillaroscopic changes within patient subgroups.</p><p><strong>Methods: </strong>This cross-sectional study enrolled 117 individuals, divided into three groups: healthy controls (N=31), systemic sclerosis (SSc) (N=49), and other connective tissue diseases (CTDs) presenting with Raynaud's phenomenon (RP) (N=37). Clinical data, including lung involvement, pulmonary artery hypertension, and skin score, as well as laboratory results, capillaroscopy findings, and eye sign (assessed by naked-eye criteria), were collected from all participants. The primary analysis compared ocular symptom scores between patients and healthy controls. Subgroup analyses and correlation assessments were exploratory.</p><p><strong>Results: </strong>Eye sign scores did not significantly differ between the combined patient group and healthy controls (<i>P</i> = 0.158). Subgroup comparisons also revealed no significant differences (<i>P</i> = 0.297 for SSc, <i>P</i> = 0.262 for other CTDs). Furthermore, no significant associations were observed between eye sign scores and capillaroscopy findings within the study groups. Additionally, no significant associations were found between eye sign scores and specific clinical manifestations. Confidence intervals were provided to reflect statistical uncertainty.</p><p><strong>Conclusion: </strong>This study found no statistically significant differences in Eye sign scores between patients and healthy controls, nor any associations with capillaroscopic abnormalities. However, due to the limited sample size and the exploratory nature of the subgroup analyses, these findings should be interpreted with caution.</p>","PeriodicalId":18361,"journal":{"name":"Medical Journal of the Islamic Republic of Iran","volume":"40 ","pages":"28"},"PeriodicalIF":0.0000,"publicationDate":"2026-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13404494/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of the Islamic Republic of Iran","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47176/mjiri.40.28","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Capillaroscopy is widely recognized for its role in evaluating microcirculation, particularly in patients with Raynaud's phenomenon and scleroderma-spectrum diseases. The eye sign may provide complementary insights into microvascular assessment. This study primarily investigates whether the eye sign can differentiate patients with systemic sclerosis (SSc) and other connective tissue diseases (CTDs) presenting with Raynaud's from healthy controls. Additionally, we explored correlations between eye sign scores and capillaroscopic changes within patient subgroups.
Methods: This cross-sectional study enrolled 117 individuals, divided into three groups: healthy controls (N=31), systemic sclerosis (SSc) (N=49), and other connective tissue diseases (CTDs) presenting with Raynaud's phenomenon (RP) (N=37). Clinical data, including lung involvement, pulmonary artery hypertension, and skin score, as well as laboratory results, capillaroscopy findings, and eye sign (assessed by naked-eye criteria), were collected from all participants. The primary analysis compared ocular symptom scores between patients and healthy controls. Subgroup analyses and correlation assessments were exploratory.
Results: Eye sign scores did not significantly differ between the combined patient group and healthy controls (P = 0.158). Subgroup comparisons also revealed no significant differences (P = 0.297 for SSc, P = 0.262 for other CTDs). Furthermore, no significant associations were observed between eye sign scores and capillaroscopy findings within the study groups. Additionally, no significant associations were found between eye sign scores and specific clinical manifestations. Confidence intervals were provided to reflect statistical uncertainty.
Conclusion: This study found no statistically significant differences in Eye sign scores between patients and healthy controls, nor any associations with capillaroscopic abnormalities. However, due to the limited sample size and the exploratory nature of the subgroup analyses, these findings should be interpreted with caution.
背景:毛细管镜检查在评估微循环方面的作用被广泛认可,特别是在雷诺现象和硬皮病谱系疾病患者中。眼征可以为微血管评估提供补充的见解。本研究主要探讨眼体征是否可以区分系统性硬化症(SSc)和其他结缔组织疾病(CTDs)患者与健康对照者。此外,我们还探讨了患者亚组内眼体征评分与毛细血管镜变化之间的相关性。方法:本横断面研究纳入117人,分为三组:健康对照组(N=31)、系统性硬化症(N=49)和其他伴有雷诺现象(RP)的结缔组织疾病(CTDs) (N=37)。收集所有参与者的临床数据,包括肺部受累、肺动脉高压、皮肤评分、实验室结果、毛细血管镜检查结果和眼征(用裸眼标准评估)。初步分析比较了患者和健康对照者的眼部症状评分。亚组分析和相关性评估是探索性的。结果:合并组与健康对照组的眼体征评分差异无统计学意义(P = 0.158)。亚组比较也显示无显著差异(SSc P = 0.297,其他CTDs P = 0.262)。此外,在研究组中没有观察到眼体征评分和毛细血管镜检查结果之间的显著关联。此外,眼体征评分与特定临床表现之间没有显著关联。提供置信区间以反映统计不确定性。结论:本研究发现患者与健康对照者的眼体征评分无统计学差异,且与毛细血管镜异常无关联。然而,由于有限的样本量和亚组分析的探索性,这些发现应该谨慎解释。